9.31
price up icon4.67%   0.415
after-market 시간 외 거래: 9.26 -0.05 -0.54%
loading
전일 마감가:
$8.895
열려 있는:
$9.14
하루 거래량:
128.95K
Relative Volume:
0.21
시가총액:
$20.54M
수익:
$1.47M
순이익/손실:
$-97.61M
주가수익비율:
-6.2483
EPS:
-1.49
순현금흐름:
$-80.90M
1주 성능:
-24.31%
1개월 성능:
-54.02%
6개월 성능:
-13.80%
1년 성능:
-33.50%
1일 변동 폭
Value
$8.82
$9.36
1주일 범위
Value
$8.35
$14.88
52주 변동 폭
Value
$3.8101
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
명칭
Lyra Therapeutics Inc
Name
전화
617-373-4600
Name
주소
480 ARSENAL WAY, WATERTOWN, MA
Name
직원
30
Name
트위터
@LyraTx
Name
다음 수익 날짜
2025-03-12
Name
최신 SEC 제출 서류
Name
LYRA's Discussions on Twitter

LYRA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LYRA
Lyra Therapeutics Inc
9.31 20.54M 1.47M -97.61M -80.90M -1.49
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-07 다운그레이드 BofA Securities Buy → Underperform
2024-05-07 다운그레이드 H.C. Wainwright Buy → Neutral
2024-05-07 다운그레이드 Jefferies Buy → Hold
2024-05-06 다운그레이드 William Blair Outperform → Mkt Perform
2023-10-06 재개 BTIG Research Buy
2023-08-31 개시 H.C. Wainwright Buy
2022-05-24 개시 Cantor Fitzgerald Overweight
2020-05-26 개시 BTIG Research Buy
2020-05-26 개시 BofA/Merrill Buy
2020-05-26 개시 Jefferies Buy
2020-05-26 개시 William Blair Outperform
모두보기

Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스

pulisher
Jun 16, 2025

Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha

Jun 16, 2025
pulisher
Jun 14, 2025

Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise

Jun 12, 2025
pulisher
Jun 10, 2025

H.C. Wainwright lifts Lyra Therapeutics stock target to $16 By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Lyra Therapeutics (LYRA) Price Target Raised by HC Wainwright & Co. | LYRA Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

H.C. Wainwright Ups Target Price for Lyra Therapeutics (LYRA) to $16 | LYRA Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Lyra Therapeutics, Inc. (NASDAQ:LYRA) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

Lyra Eyes US Filing For LYR-210 After Surprise ENLIGHTEN 2 Win - insights.citeline.com

Jun 06, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Has $59,000 Stock Position in Lyra Therapeutics, Inc. (NASDAQ:LYRA) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Study: LYR-210 Shows Promise in Chronic Rhinosinusitis With Nasal Polyps - Pharmacy Times

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Makes New Investment in Lyra Therapeutics, Inc. (NASDAQ:LYRA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Best Biotech Stocks To Watch Now – June 2nd - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Biotech Triumphs: Lyra, Vera, And US Gold Shine Bright - Finimize

Jun 03, 2025
pulisher
Jun 03, 2025

Lyra Therapeutics stock hits 52-week high at $28.66 By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Lyra Therapeutics Stock Skyrockets On Positive Trial Data For Its Nasal Implant: Retail’s Thrilled - Asianet Newsable

Jun 03, 2025
pulisher
Jun 03, 2025

Lyra Therapeutics reports positive phase 3 trial results for CRS treatment By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Applied Digital Corp, Meta Platforms, Alphabet, Lyra Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Stock Skyrockets On Positive Trial Data For Its Nasal Implant: Retail’s Thrilled By Stocktwits - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

Redemption for Lyra as second phase III rhinosinusitis trial hits goal - BioWorld MedTech

Jun 02, 2025
pulisher
Jun 02, 2025

One year after massive layoffs, Lyra stock soars 400% on trial win - The Business Journals

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics (LYRA) Surges 376% on Positive Phase 3 Trial R - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics (LYRA) Surges 376% on Positive Phase 3 Trial Results - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Microcap Lyra Therapeutics surges 376% on phase 3 rhinosinusitis data - Seeking Alpha

Jun 02, 2025
pulisher
Jun 02, 2025

Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Shares Climb Over 500% After Major CRS Trial Win - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Spikes 417% as LYR-210 Redefines CRS Therapy - Wall Street Pit

Jun 02, 2025
pulisher
Jun 02, 2025

LYR-210 Nasal Implant for CRS Brings Symptom Relief in Phase 3 ENLIGHTEN 2 - HCPLive

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics says ENLIGHTEN 2 trial of LYR-210 met primary endpoint - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Soars on Breakthrough Nasal Implant Results - RagingBull

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Shares Soar 603.25% to $34.67 on LYR-210 Trial Success - Trading Pedia

Jun 02, 2025
pulisher
Jun 02, 2025

Transcript : Lyra Therapeutics, Inc.Special Call - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics stock hits 52-week high at $28.66 - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

This penny stock just spiked 550% in a day; Time to buy? - Finbold

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Stock (LYRA) Rockets 530% on Phase 3 Trial Results - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Reports Positive Results From The Enlighten 2 Phase 3 Trial Of Lyr-210 - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Says Phase 3 Trial of Nasal Implant for Chronic Rhinosinusitis Meets Endpoints - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Why Is Lyra Therapeutics Stock Surging Over 400% On Monday? - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Announces Positive Phase 3 Trial Results - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

LYRA Sees Promising Results in ENLIGHTEN 2 Phase 3 Trial for CRS Treatment | LYRA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics reports positive phase 3 trial results for CRS treatment - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics stock soars on positive Phase 3 trial results By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics stock soars on positive Phase 3 trial results - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS) - GlobeNewswire

Jun 02, 2025
pulisher
Jun 01, 2025

Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World

Jun 01, 2025

Lyra Therapeutics Inc (LYRA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):